Source link : https://www.newshealth.biz/health-news/osteoporosis-biosimilar-okd-new-endo-guidelines-a-hot-spot-for-stealing-ozempic/
(MedPage Today) — The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture and increasing bone mass in several patient populations, said maker Samsung Bioepis. A group of 50… Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/114260 Author : Publish date : 2025-02-18 20:35:34 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-18 20:35:34
Copyright for syndicated content belongs to the linked Source.